Evidence map›Paper›PMID 22606016›Full record

ArticleInternational journal of molecular sciences2012

Study on the immunomodulation effect of Isodon japonicus extract via splenocyte function and NK anti-tumor activity.

Yu-Jin Hwang, Jaehyun Kim, Dong-Sik Park, Kyung-A Hwang

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Four NewMolecules (Basel, Switzerland) · 2019
    Article
  4. Article
  5. Article
  6. Cytotoxicity and pharmacogenomics of medicinal plants from traditional korean medicine.Evidence-based complementary and alternative medicine : eCAM · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yu-Jin HwangDepartment of Agrofood Resources, National Academy of Agricultural Science, RDA, Suwon 441-853, Korea.
Jaehyun KimDepartment of Agrofood Resources, National Academy of Agricultural Science, RDA, Suwon 441-853, Korea.
Dong-Sik ParkDepartment of Agrofood Resources, National Academy of Agricultural Science, RDA, Suwon 441-853, Korea.
Kyung-A HwangDepartment of Agrofood Resources, National Academy of Agricultural Science, RDA, Suwon 441-853, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we investigated the potential immune-enhancing activity of Isodon japonicus on murine splenocyte and natural-killer (NK) cells in vitro. The ethanol extract of I. japonicus significantly enhanced the proliferation of splenocyte and induced the significant enhancement of NK cells' activity against tumor cells (YAC-1). In addition, I. japonicus increased the production of interferon (IFN)-γ and tumor necrosis factor (TNF)-α, suggesting that the increase in NK cell cytotoxicity could be due to the enhancement of the NK cell production of both cytokines. Taken together, I. japonicus extract inhibited the growth of human leukemia cells (K562) by 74%. Our observation indicated that the anti-tumor effects of I. japonicus may be attributed to its ability to serve as a stimulant of NK anti-tumor activity. In addition, our results support the development of functional food studies on I. japonicus.

Indexed as

AnimalsB-LymphocytesCell Line, TumorCell ProliferationHT29 CellsHumansImmunologic FactorsImmunomodulationInterferon-gammaIsodonKiller Cells, NaturalLeukemiaMaleMCF-7 CellsMedicine, Korean TraditionalMiceImmunologic FactorsInterferon-gammaPlant ExtractsTumor Necrosis Factor-alphacytokineIsodon japonicusnatural killer cellsplenocyte

Identifiers

PMID22606016
PMCPMC3344252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.